The T-helper1/T-helper2 paradigm: still valid for drug discovery but with some essential refinement.
Korstanje
Cees
C
D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000276:immunology; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy / Q000276:immunology; D018417:Th1 Cells / Q000187:drug effects* / Q000276:immunology; D018418:Th2 Cells / Q000187:drug effects* / Q000276:immunology
D000893:Anti-Inflammatory Agents